Effect of chemoradiotherapy with gemcitabine and cisplatin on locoregional control in patients with primary inoperable pancreatic cancer

World Journal of Surgery

Volumn 28, Issue 10, 2004, Pages 1011-1018

  Wilkowski, Ralf ^a   Thoma, Martin ^a   Schauer, Rolf ^a   Wagner, Andreas ^a   Heinemann, Volker ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHOLANGITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; LAPAROTOMY; LEUKOPENIA; LYMPH NODE; MALE; PANCREAS CANCER; PANCREAS RESECTION; RADIATION DOSE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY, CONFORMAL;

EID: 12144269022     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-004-7338-z     Document Type: Article

References (39)

1. Kelly DM, Benjamin IS. Pancreatic carcinoma. Ann. Oncol. 1995;6:19-28
2. Parker SL, Tong T, Bolden S, et al. Cancer statistics. CA Cancer J. Clin. 1996;46:5-27
3. Gastrointestinal Tumor Study Group. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil) and high dose radiation + 5-fluorouracil. Cancer 1981;48:1705-1710
4. Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J. Natl. Cancer Inst. 1988;23:213-219
5. Brunner T, Grabenbauer G, Baum U, et al. Adjuvant and neoadjuvant radiochemotherapy in ductal pancreatic carcinoma. Strahlenther. Onkol. 2000;6:265-273
6. Jessup JM, Steele G, Mayer RJ, et al. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch. Surg. 1993;128:559-564
7. Pilepich MV, Miller HH. Preoperative irradiation in carcinoma of the pancreas. Cancer 1980;46:1945-1949
8. Burris HA, Moore MJ, Andersen J. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J. Clin. Oncol. 1997;15:2403-2413
9. Carmichael J, Fink U, Russell RC, et al. Phase II study of gemcitabine in patients with advanced pancreatic cancer. Br. J. Cancer 1996;73:101-105
10. Casper ES, Green MR, Kelsen DP, et al. Phase II trial of gemcitabine (2,2′-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas. Invest. New Drugs 1994;12:29-34
11. Lawrence TS, Chang EY, Hahn TM, et al. Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine. Int. J. Radiat. Oncol. Biol. Phys. 1996;34:867-872
12. Mose S, Karapetian M, Jüling-Pohlit L, et al. Verstôrkung der radiotherapeutischen Wirkung auf HeLa-Zellen durch Gemcitabine. Strahlenther. Onkol. 1999;175:78-83
13. Bergman AM, Ruiz van Haperen VW, Veerman G, et al. Synergistic interaction between cisplatin and gemcitabine in vitro. Clin. Cancer Res. 1996;2:521-530
14. Heinemann V. Gemcitabine-based combination treatment of pancreatic cancer. Semin. Oncol. 2002;29:25-35
15. Philip PA, Zalupski M, Vaitkevicius V, et al. Phase II study of gemcitabine and cisplatinum in advanced or metastatic pancreatic cancer. Proc. Am. Soc. Clin. Oncol. 1999;18:A274
16. Snady H, Bruckner H, Cooperman A, et al. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma: an outcomes trial. Cancer 2000;89:314-327
17. Spitz FR, Abbruzzese JL, Lee JE, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J. Clin. Oncol. 1997;15:928-937
18. Magnin V, Moutardier V, Giovannini MH, et al. Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 2003;55:1300-1304
19. White RR, Hurwitz HI, Morse MA, et al. Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. Ann. Surg. Oncol. 2001;8:758-765
20. Rothenberg ML, Moore MJ, Cripps MC, et al. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann. Oncol. 1996;7:347-353
21. Blackstock AW, Bernard SA, Richards F, et al. Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer. J. Clin. Oncol. 1999;17:2208-2212
22. Epelbaum R, Rosenblatt E, Nasrallah S, et al. A phase II study of gemcitabine (Gem) combined with radiation therapy (RT) in patients with localized, unresectable pancreatic cancer. Proc. Am. Soc. Clin. Oncol. 2000;19:A1029
23. Hoffman JP, McGinn CJ, Szarka C, et al. A phase I study of preoperative gemcitabine (GEM) with radiation therapy (RT) followed by postoperative GEM for patients with localized, resectable pancreatic adenocarcinoma (PaC). Proc. Am. Soc. Clin. Oncol. 1998;17:A1090
24. Kudrimoti M, Regine W, John W, et al. Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I/II study. Proc. Am. Soc. Clin. Oncol. 1999;18:A928
25. Maurer U, Stegmeier P, Bolte R, et al. Gemcitabine (G) in combination radiation therapy (RT) in stage III-IV pancreatic cancer: first results of a current phase I study. Eur. J. Cancer 1999;35:A544
26. McGinn CJ, Smith DC, Szarka CE, et al. A phase I study of gemcitabine (GEM) in combination with radiation therapy (RT) in patients with localized, unresectable pancreatic cancer. Proc. Am. Soc. Clin. Oncol. 1998;17:A1014
27. Reyes-Vidal J, Rodriguez P, Reyes J, et al. Chemoradiation therapy with gemcitabine (Gem) in advanced pancreatic cancer. Proc. Am. Soc. Clin. Oncol. 2000;19:A1183
28. Wilkowski R, Heinemann V, Rau H. Radiochemotherapy including gemcitabine and 5-fluorouracil for treatment of locally advanced pancreatic cancer. Proc. Am. Soc. Clin. Oncol. 2000;19:A1078
29. Yavuz A, Aydin F, Yavuz M, et al. A phase I trial of radiation therapy (RT) plus concurrent fixed dose amifostine (Ami) with escalating doses of twice-weekly gemcitabine in advanced pancreatic cancer. Proc. Am. Soc. Clin. Oncol. 2000;19:A1105
30. De Lange SM, van Groeningen CJ, Meijer OW, et al. Gemcitabine- radiotherapy in patients with locally advanced pancreatic cancer. Eur. J. Cancer 2002;38:1212-1217
31. Ikeda M, Okada S, Tokuuye K, et al. A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer. Br. J. Cancer 2002;86:1551-1554
32. Brunner TB, Grabenbauer GG, Klein P, et al. Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 2003;55:144-153
33. Talamonti MS, Catalano PJ, Vaughn DJ, et al. Eastern Cooperative Oncology Group phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity. J. Clin. Oncol. 2000;18:3384-3389
34. Crane CH, Janjan NA, Evans DB, et al. Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. Int. J. Pancreatol. 2001;29:9-18
35. Wilkowski R, Stoffregen C, Rau H-G, et al. Chemoradiation with gemcitabine (G) in primary inoperable pancreatic cancer. Proc. Am. Soc. Clin. Oncol. 2001;20:A2317
36. McGinn CJ, Zalupski MM, Shureiqi I, et al. Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer. J. Clin. Oncol. 2001;19:4202-4208
37. Bajetta E, Di Bartolomeo M, Stani SC, et al. Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study. Int. J. Radiat. Oncol. Biol. Phys. 1999;45:285-289
38. Mawdsley S, Hall M, Glynne-Jones R. Locally advanced pancreatic cancer treated with radiation and 5-fluorouracil. Clin. Oncol. (R. Coll. Radiol.) 2002;14:308-312
39. Osti MF, Costa AM, Bianciardi F, et al. Concomitant radiotherapy with protracted 5-fluorouracil infusion in locally advanced carcinoma of the pancreas: a phase II study. Tumori 2001;87:398-401